Vagus nerve stimulation for refractory status epilepticus: A systematic review.

SeizureJul 25, 2026 (epub)
Clinical ResearchNeurology

Chun-Lin Kuo, Hung-Yu Lin, Chia-Kuang Tsai et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated the efficacy of vagus nerve stimulation (VNS) in 61 patients with super-refractory status epilepticus (SRSE). The study found a 90% cessation rate of refractory status epilepticus after VNS implantation, with a median time to cessation of 12.7 days. However, only 38% of patients achieved long-term seizure freedom.

Key findings

  • 90% of patients experienced cessation of refractory status epilepticus after VNS implantation.
  • 38% of patients with follow-up of 12 months achieved seizure freedom.
  • 61% of patients had unfavorable functional outcomes, with 31% mortality.

Why it matters

Refractory status epilepticus is a critical condition with high morbidity and mortality. Understanding the potential role of VNS in managing this condition can inform treatment strategies and improve patient outcomes.

What to keep in mind

The review is limited by potential publication bias and the exploratory nature of subgroup analyses.

Source

Published in Seizure. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.